Mebeverinhydrochlorid Aristo

Mebeverine Hydrochloride, the active ingredient in Mebeverinhydrochlorid Aristo, is an antispasmodic presented as an oral formulation for oral use. It is employed to relieve intestinal spasm associated with functional gastrointestinal disorders such as irritable bowel syndrome in adult patients. The product conforms to EU quality standards and is intended for patients requiring symptomatic management of bowel motility disturbances.

GNH USA supplies Mebeverinhydrochlorid Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery, regulatory compliance, and support for pharmacovigilance activities across diverse markets.

Mebeverine Hydrochloride is employed in the management of functional gastrointestinal disorders that are characterized by abnormal smooth‑muscle activity and recurrent abdominal discomfort. - Irritable bowel syndrome: reduces abdominal pain, cramping and irregular bowel habits by relaxing intestinal smooth muscle. - Functional bowel disorders: alleviates spasmodic episodes and improves overall bowel function. - Spastic colon: eases colonic spasm and associated discomfort. - Diverticular disease: helps reduce colonic spasm and associated pain.

Mebeverine Hydrochloride may cause adverse reactions in some patients.

Common Side Effects: - Nausea: mild to moderate feeling of stomach upset. - Dry mouth: reduced salivation leading to throat discomfort. - Headache: transient cranial pain of varying intensity. - Dizziness: occasional light‑headed sensation. - Abdominal discomfort: mild pain or bloating. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Angioedema: rapid swelling of face, lips, tongue or throat. - Severe hypotension: marked drop in blood pressure causing faintness. - Cardiac arrhythmia: irregular heart rhythm in susceptible individuals. - Hepatotoxicity: signs of liver injury such as jaundice. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before using Mebeverine Hydrochloride, consider the following precautions. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown excretion; weigh benefits against potential risks. - Renal impairment: dose adjustment may be required; monitor renal function. - Hepatic impairment: use with caution; monitor liver enzymes. - Drug interactions: review all concomitant medications for potential interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Mebeverine Hydrochloride can interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Concomitant use with other antispasmodics: may cause excessive smooth‑muscle relaxation. - Monoamine oxidase inhibitors (MAOIs): potential additive effects on gastrointestinal motility.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may increase dry‑mouth sensation. - Opioids: additive risk of constipation. - Tricyclic antidepressants: may enhance gastrointestinal side effects.